Novavax
NVAX
186 hedge funds and large institutions have $1.59B invested in Novavax in 2016 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 47 reducing their positions, and 21 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
52% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 21
40% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 47
39% more capital invested
Capital invested by funds: $1.15B → $1.59B (+$445M)
6% more funds holding
Funds holding: 175 → 186 (+11)
57% less call options, than puts
Call options by funds: $15.6M | Put options by funds: $36M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$12.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.94M |
| 3 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$3.9M |
| 4 |
D.E. Shaw & Co
New York
|
+$3.52M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$3.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$18.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$17.9M |
| 3 |
DM
Deerfield Management
New York
|
-$12.7M |
| 4 |
Millennium Management
New York
|
-$5.85M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.28M |
NVAX Hedge Fund Activity: Q2 2016 in Review
186 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2016, worth a combined $1.59B — up 39% from $1.15B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new NVAX positions and 21 closed out — a net gain of 11 holders — while 66 added to existing stakes and 47 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $12.2M. The largest seller was State Street, cutting an estimated $18.9M.
- 186 institutional investors held Novavax (NVAX) as of Q2 2016, up from 175 in Q1 2016.
- Funds reported $1.59B of Novavax stock for Q2 2016, up 39% quarter-over-quarter.
- 32 funds opened new Novavax positions in Q2 2016 and 21 closed out, a net change of +11 holders.
- The largest Novavax buyer in Q2 2016 was Janus Henderson Investors US, an estimated $12.2M added.
- The largest Novavax seller in Q2 2016 was State Street, an estimated $18.9M sold.
Based on aggregated 13F filings for Q2 2016.